These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12809979

  • 1. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).
    Edland SD, Wavrant-De Vriesé F, Compton D, Smith GE, Ivnik R, Boeve BF, Tangalos EG, Petersen RC.
    Neurosci Lett; 2003 Jul 10; 345(1):21-4. PubMed ID: 12809979
    [Abstract] [Full Text] [Related]

  • 2. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
    Edland SD.
    J Mol Neurosci; 2004 Jul 10; 23(3):213-7. PubMed ID: 15181249
    [Abstract] [Full Text] [Related]

  • 3. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L, Yang JD, Guo TW, Sun Y, Duan SW, Chen WY, Pan YX, Feng GY, He L.
    Neurology; 2004 Jul 27; 63(2):241-5. PubMed ID: 15277615
    [Abstract] [Full Text] [Related]

  • 4. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
    Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S.
    Am J Pathol; 2003 Jan 27; 162(1):313-9. PubMed ID: 12507914
    [Abstract] [Full Text] [Related]

  • 5. Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis.
    Cheng H, Wang L, Shi T, Shang Y, Jiang L.
    Int J Neurosci; 2015 May 27; 125(5):328-35. PubMed ID: 25105907
    [Abstract] [Full Text] [Related]

  • 6. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
    Vepsäläinen S, Parkinson M, Helisalmi S, Mannermaa A, Soininen H, Tanzi RE, Bertram L, Hiltunen M.
    J Med Genet; 2007 Sep 27; 44(9):606-8. PubMed ID: 17496198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, Salemi M, Nicoletti F, Ferri R.
    Neurosci Lett; 2007 Jun 04; 419(3):195-8. PubMed ID: 17498878
    [Abstract] [Full Text] [Related]

  • 10. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
    Björk BF, Katzov H, Kehoe P, Fratiglioni L, Winblad B, Prince JA, Graff C.
    Neurobiol Aging; 2007 Sep 04; 28(9):1374-80. PubMed ID: 16876916
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.
    Biol Psychiatry; 2004 Nov 01; 56(9):670-6. PubMed ID: 15522251
    [Abstract] [Full Text] [Related]

  • 12. Combined risk effects of IDE and NEP gene variants on Alzheimer disease.
    Vepsäläinen S, Helisalmi S, Mannermaa A, Pirttilä T, Soininen H, Hiltunen M.
    J Neurol Neurosurg Psychiatry; 2009 Nov 01; 80(11):1268-70. PubMed ID: 19864659
    [Abstract] [Full Text] [Related]

  • 13. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ, Folstein MF.
    Neurobiol Aging; 2006 Feb 01; 27(2):190-8. PubMed ID: 16399206
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
    Carrieri G, Bonafè M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, Feraco E, Andreev KF, Yashin AI, Franceschi C, De Benedictis G.
    Hum Genet; 2001 Mar 01; 108(3):194-8. PubMed ID: 11354629
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O.
    J Neurol; 2006 Feb 01; 253(2):181-5. PubMed ID: 16096813
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 01; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 17. Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.
    Lilius L, Froelich Fabre S, Basun H, Forsell C, Axelman K, Mattila K, Andreadis A, Viitanen M, Winblad B, Fratiglioni L, Lannfelt L.
    Neurosci Lett; 1999 Dec 17; 277(1):29-32. PubMed ID: 10643890
    [Abstract] [Full Text] [Related]

  • 18. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P, Moore P, Bryden L, Myers A, Doil LM, Tacey KM, Gibson AM, McKeith IG, Perry RH, Morris CM, Thal L, Morris JC, O'Donovan MC, Lovestone S, Grupe A, Hardy J, Owen MJ, Williams J, Goate A.
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul 05; 136B(1):62-8. PubMed ID: 15858813
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY, Sadovnick AD, Feldman H.
    CMAJ; 2004 Oct 12; 171(8):863-7. PubMed ID: 15477624
    [Abstract] [Full Text] [Related]

  • 20. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.
    Neurosci Lett; 2008 Aug 01; 440(2):145-9. PubMed ID: 18555606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.